Max Healthcare Institute Limited has announced the allotment of 216,084 equity shares under its Employee Stock Option Scheme (ESOP) 2022, as approved by the Nomination & Remuneration Committee on November 14, 2025. This move is part of the company's strategy to reward eligible employees by allowing them to exercise their vested stock options. With this allotment, the company's paid-up equity share capital increases from ₹972,23,64,310 to ₹972,45,25,150, reflecting continued growth in employee engagement and investment.

Prior to this issuance, Max Healthcare had a total of 97,22,36,431 equity shares outstanding, which now rises to 97,24,52,515 shares following the allotment. The shares have a face value of ₹10 each, and the exercise prices for the options range from ₹350 to ₹700 per share, with corresponding premiums of ₹340 and ₹690. This strategic allotment underscores the company’s commitment to enhancing employee satisfaction and retaining talent through equity participation.

The regulatory framework governing this allotment aligns with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The relevant details and the implications of this allotment have been documented and shared with both the BSE and NSE. The shares allotted are identical in all respects to existing shares, ensuring that there are no disparities in shareholder rights. This initiative not only strengthens the company's financial structure but also reinforces its position as a competitive player in the healthcare sector.